Spectracure AB Stock: price and insider trades · Sweden

This page follows insider dealings at Spectracure AB as filed with Finansinspektionen, a company from the Health Care sector. Over the twelve months to 18 October 2026, 14 filings were filed, from 5 insiders.

Purchases and sales both appear in the filings: 8 purchases (3 insiders, €140k) and 4 sales (3 insiders, €23k). The net balance comes to €117k on the buying side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Among those who bought: 3 board members and 1 chief executive. The largest single trade was a purchase of €104k by MK Capital Invest AB, published on 5 August 2026, equal to 8.7% of the market capitalisation.

For context, the typical company on the same exchange (median of 890 companies) published 7 filings over the same period, against 14 filings here. Our records for Spectracure AB go back to 2025, with 10 purchases and 4 sales on the open market in total.

In all, 3 purchases were made within 30 days of a purchase by another insider of the company. Purchases made close together by different insiders form what is called a cluster. The latest purchase is recent: it was published 29 days ago, on 18 September 2026. Filings reach the Finansinspektionen feed a median of 2 days after the trade. The legal deadline for notifying a trade is three business days (MAR article 19).

In the same sector, recent insider purchases at Anixa Biosciences Inc and Vivos Inc also feature in our signals. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.